Market Overview

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

226.71 +8.61 (3.95%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/20/20BernsteinInitiates Coverage OnOutperform275.0
10/30/20Credit SuisseMaintainsOutperform285.0
10/30/20SVB LeerinkMaintainsMarket Perform257.0
10/28/20UBSInitiates Coverage OnBuy287.0
10/19/20Morgan StanleyMaintainsEqual-Weight249.0
10/15/20SVB LeerinkMaintainsMarket Perform267.0
10/13/20Morgan StanleyMaintainsEqual-Weight281.0
8/24/20SVB LeerinkMaintainsMarket Perform283.0
7/31/20Cantor FitzgeraldMaintainsOverweight305.0
7/31/20SVB LeerinkMaintainsMarket Perform274.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter